Concepedia

Peter Angehrn

PA

Statistics

Publications

35

Citations

1.6K

H-Index

22

Active since

1972

Affiliations

Roche (Switzerland)(Current)

Basilea Pharmaceutica (Switzerland)

Peter Angehrn is an author at Roche (Switzerland) specializing in antibacterial pharmacology, antibiotic resistance, and pharmacy.

Publications per year

1972–2011

35

Publications

35

In Vitro and In Vivo Properties of Ro 63-9141, a Novel Broad-Spectrum Cephalosporin with Activity against Methicillin-Resistant Staphylococci

Paul Hebeisen, Ingrid Heinze‐Krauss, Peter Angehrn et al. · Antimicrobial Agents and Chemotherapy · 2001 · 214 citations · Full text

, , +16

Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism

R.L. Then, Peter Angehrn · Antimicrobial Agents and Chemotherapy · 1982 · 155 citations

, , +17

Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies

Peter Angehrn, Peter Probst, R. Reiner et al. · Antimicrobial Agents and Chemotherapy · 1980 · 91 citations · Full text

, , +14

Design, synthesis, and structure–activity relationship studies of ATP analogues as DNA gyrase inhibitors

Thomas Lübbers, Peter Angehrn, Hans Gmünder et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 82 citations

, , +13

Design, synthesis, and structure–activity relationship studies of new phenolic DNA gyrase inhibitors

Thomas Lübbers, Peter Angehrn, Hans Gmünder et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 82 citations

, , +14

1–5 of 35